Green Pine Leads Series Pre-B Plus Round In Chinese Genome Editing Firm EdiGene

Chinese genome editing technologies developer EdiGene Inc. has secured about US$10 million in its series pre-B plus round of financing led by Chinese venture capital firm Green Pine Capital Partners, said EdiGene in a statement released on Monday. Other investors including IDG Capital, leading investor in its series A round, biomedical venture capital firm Lilly […]

Green Pine Leads Series Pre-B Plus Round In Chinese Genome Editing Firm EdiGene appeared first on China Money Network.

Read the original article: China Money Network